3‐Hydroxy‐2‐methylbutyryl‐CoA dehydrogenase deficiency

  • V. R. Sutton
    Department of Molecular and Human Genetics USA
  • W. E. O'Brien
    Department of Molecular and Human Genetics USA
  • G. D. Clark
    Department of Neurology Baylor College of Medicine Houston Texas
  • J. Kim
    Neurology Shreveport Louisiana USA
  • R. J. A. Wanders
    Laboratory of Genetic Metabolic Diseases, Department of Pediatrics and Clinical Chemistry, Academic Centre University of Amsterdam Amsterdam The Netherlands

書誌事項

公開日
2003-07
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1023/a:1024083715568
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p><jats:bold>Summary:</jats:bold> A boy now 8 years old presented at 21 months of age with developmental arrest, followed by regression, cortical blindness and myoclonic seizures. Urine organic acid analysis revealed 3‐hydroxy‐2‐methylbutyric acid and tiglyglycine; 3‐ketothiolase enzyme activity was normal and he was subsequently found to have 3‐hydroxy‐2‐methylbutyryl‐CoA dehydrogenase deficiency.</jats:p>

収録刊行物

被引用文献 (3)*注記

もっと見る

問題の指摘

ページトップへ